Yuhan
Corporation - Product Pipeline Review - 2014
Summary
Global Markets
Direct's, 'Yuhan Corporation - Product Pipeline Review - 2014', provides an
overview of the Yuhan Corporation's pharmaceutical research and development
focus.
This report provides
comprehensive information on the current therapeutic developmental pipeline of
Yuhan Corporation's, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. It also reviews latest updates, and
featured news and press releases, along with special features on late-stage and
discontinued projects.
Global Markets Direct's
report features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using data and
information sourced from Global Markets Direct's proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct's team. Drug profiles/records
featured in the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set of
information. Additionally, processes including live news & deals tracking,
browser based alert-box and clinical trials registries tracking ensure that the
most recent developments are captured on a real time basis.
The report enhances
decision making capabilities and help to create effective counter strategies to
gain competitive advantage. It strengthens R&D pipelines by identifying new
targets and MOAs to produce first-in-class and best-in-class products.
Note*:
Certain sections in the report may be removed or altered based on the availability
and relevance of data for the indicated disease.
Scope
- The report provides
brief overview of Yuhan Corporation including business description, key
information and facts, and its locations and subsidiaries
- The report reviews
current pipeline of Yuhan Corporation's human therapeutic division and enlists
all their major and minor projects
- The report features
product description and descriptive mechanism of action for key pipeline
products along with the product's developmental history and major milestones
Reasons
to buy
- Evaluate Yuhan
Corporation's strategic position with total access to detailed information on
its product pipeline
- Assess the growth
potential of Yuhan Corporation in its therapy areas of focus
- Identify new drug
targets and therapeutic classes in the Yuhan Corporation's R&D portfolio
and develop key strategic initiatives to reinforce pipeline in those areas
About
Radiant Insights
Radiant Insights is a
platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For
more information visit, Radiant Insights
Contact
Details:
Michelle Thoras
Corporate Sales
Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free:
1-888-202-9519
No comments:
Post a Comment